Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study
Journal of Osteoporosis · 2011 · 2011 · 1-8
DOI: 10.4061/2011/510398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Osteoporosis, 2011. Verfasst von K Aloumanis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Pharmaserve-Lilly, Kifissia, 14564 Athens, Greece. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Objective
To evaluate fracture incidence, effects on health-related quality of life(QoL), back pain (BP) occurrence and treatment compliance in Greek post-menopausal osteoporotic women treated with teriparatide (TPTD) for up to 18 months, in a naturalistic setting.
Methods
301 patients provided baseline information on demographic characteristics, fracture history, osteoporosis-related medication and risk factors. During treatment, QoL and BP severity were evaluated.
Results
Mean (SD) age was 69.5 (±8.5) years. Fracture history was reported by 92.5% of patients. Incidence of fractures (per 10,000 patients/years) ranged from 402 during 0–6 months of treatment, to 346 during 12–18 months. All 5 dimensions of QoL showed improvement. At baseline and 18 months, BP was reported by 93.2% and 64.2% of patients, respectively. BP and limitation of activities were quantified as moderate or severe by 89.9% and 62.3% of patients at baseline versus 32.4% and 14.8% at 18 months. Patients on treatment at 6, 12, 17, and 18 months were 92.6%, 88.3%, 79.6%, and 36.5%, respectively.
Conclusions
In the Greek EFOS study cohort, patients prescribed TPTD were severely osteoporotic, with considerable health-related problems. Significant improvements in QoL and BP together with low fracture rates and high compliance have been recorded during treatment.
Autor:innen und Institutionen
- Department of Medical Research, Pharmaserve-Lilly, Kifissia, 14564 Athens, Greece.
Zitieren
APA
Aloumanis, K., Karras, D., Drossinos, V., Korelis, E., & Polydorakis, A. (2011). Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study. Journal of Osteoporosis, 2011, 1-8. https://doi.org/10.4061/2011/510398
Vancouver
Aloumanis K, Karras D, Drossinos V, Korelis E, Polydorakis A. Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study. Journal of Osteoporosis. 2011;2011:1-8. doi:10.4061/2011/510398
BibTeX
@article{Aloumanis2011,
author = {Aloumanis, K and Karras, D and Drossinos, V and Korelis, E and Polydorakis, A},
title = {Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study},
journal = {Journal of Osteoporosis},
year = {2011},
volume = {2011},
pages = {1--8},
doi = {10.4061/2011/510398}
}
EUVIMED